Sintilimab (anti-PD-1)
CAS: 2072873-06-2
Ref. TM-T35394
| 1mg | 158,00 € | ||
| 5mg | 398,00 € | ||
| 10mg | 685,00 € | ||
| 25mg | 1.012,00 € | ||
| 50mg | A consultar |
Información del producto
- IBI308, Sintilimab (anti-PD-1)
Sintilimab (IBI308) is a humanized IgG4 monoclonal antibody with significant anti-tumor activity that restores endogenous anti-tumor T-cell responses by binding to PD-1 and thereby blocking the interaction of PD-1 with its ligands (PD-L1 and PL-L2).Sintilimab is used in combination with other compounds for the treatment of classical Hodgkin's lymphoma, non-cellular lung cancer and esophageal cancer. Sintilimab is used in combination with other compounds to treat classical Hodgkin's lymphoma, non-small cell lung cancer and esophageal cancer.
Propiedades químicas
Consulta técnica sobre: TM-T35394 Sintilimab (anti-PD-1)
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
